Johnson & Johnson's Fiscal Year is From January To December.
The item "Ebitda-Interest-Coverage" stands at 59.31 as of 09/30/2025, the highest value since 03/31/2023.
As of the end of Johnson & Johnson's third quarter, the item "Ebitda Interest Coverage" stands at 59.31. This represents an increase of 40.09 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 77.59 percent compared to the value the year prior.
The 1 year change in percent is 77.59.
The 3 year change in percent is -59.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebitda Interest Coverage | 905,699,262,464.00 |
![]() | AbbVie Inc - Ebitda Interest Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebitda Interest Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebitda Interest Coverage | 280,205,508,085.11 |
![]() | Novartis AG - Ebitda Interest Coverage | 255,096,620,580.91 |